Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10294300 Antibody constructs for DLL3 and CD3

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
August 1, 2016
0
Date of Patent
May 21, 2019
0
Patent Application Number
15225107
0
Patent Citations Received
‌
US Patent 11498964 Antibody constructs for CDH19 and CD3
‌
US Patent 10683351 Antibody constructs for DLL3 and CD3
‌
US Patent 10781264 PSMA and CD3 bispecific T cell engaging antibody constructs
‌
US Patent 10981998 Cross-species-specific single domain bispecific single chain antibody
‌
US Patent 11591396 Antibody constructs for DLL3 and CD3
‌
US Patent 11434302 Bispecific T cell engaging antibody constructs
‌
US Patent 11447567 Antibody constructs for FLT3 and CD3
‌
US Patent 11884720 Antibody constructs for MSLN and CD3
0
‌
US Patent 11976133 Bispecific T cell engagers
0
‌
US Patent 11987633 Cross-species-specific single domain bispecific single chain antibody
0
•••
Patent Inventor Names
Elisabeth Nahrwold
0
Christoph Dahlhoff
0
Claudia Blümel
0
Jochen Pendzialek
0
Patrick Hoffmann
0
Peter Kufer
0
Ralf Lutterbüse
0
Tobias Raum
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10294300
0
Patent Primary Examiner
‌
Bridget E Bunner
0

Find more entities like US Patent 10294300 Antibody constructs for DLL3 and CD3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo